Clinical Trial Update: MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial update for MGD014 in HIV-1-infected individuals on suppressive ART has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MGD014 (MGD014)

Snippet

Sponsor: MacroGenics | Conditions: HIV-1-infection | Phase 1 | Status: COMPLETED | Results posted: 2022-09-02